← Leaderboards
Arfaan Rampersaud
Columbus Nanoworks, Inc.
$2,325,348
Attributed
$2,325,348
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.5M · FY2013–23$2M$1.5M$1M$500K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$2,325,348 · 4
By mechanism
N44$1,499,656 · 1
N43$825,692 · 3
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “In Vivo”
- David Heimbrook · Leidos Biomedical Research, Inc.$371,850,582
- Leonard Freedman · Leidos Biomedical Research, Inc.$304,459,298
- Dennis R. Burton · Scripps Research Institute$212,708,174
- Mark S Klempner · Tufts Medical Center$128,021,180
- Florian Krammer · Icahn School Of Medicine At Mount Sinai$104,723,856
- David M. Margolis · University Of Texas Sw Med Ctr/Dallas$98,374,200
Research focus
In VivoIn VitroSmall Business Innovation Research GrantImageLabelNanodiamondBiologicalBiocompatibleBaseAntibodiesCancer BiomarkersCancer ImagingCancer ImmunotherapyCancer PatientBreast Cancer PatientBlinkingAnti-Pd-L1ComplementConsensusDetectionDetection LimitDiagnosticDiagnostic TestsComparative Study
Grant awards (4)
SBIR TOPIC 425 PHASE I: POSTURE ANALYSIS THROUGH MACHINE LEARNING (PATHML)$354,994
N43 · FY2023 · CA · contact PI
Topic 396 - Imaging for Cancer Immunotherapies-Moonshot$299,999
N43 · FY2019 · CA · contact PI
IGF::OT::IGF$1,499,656
N44 · FY2015 · HL · contact PI
FLUORESCENT NANODIAMONDS FOR IN VITRO AND IN VIVO BIOLOGICAL IMAGING- SBIR TOPIC$170,699
N43 · FY2013 · HL · contact PI